TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Courtney O'Konek
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Olema Pharmaceuticals plans to launch a public offering of common stock or pre-funded warrants, with TD Cowen acting as book-running manager. The offering is subject to market conditions and regulatory approvals.

Insights
AAPL   positive

Beat quarterly earnings estimates and reported record iPhone upgrades in September


OLMA   neutral

The company is pursuing a standard public offering to raise capital, which is a typical financial strategy for clinical-stage pharmaceutical companies seeking to fund research and development